Aminoglycoside-associated nephrotoxicity in extrahepatic obstructive jaundice

Area of Science:

• Nephrology
• Pharmacology
• Hepatology

Background:

• Biliary obstruction is known to increase renal sensitivity to gentamicin.
• Aminoglycoside nephrotoxicity is a significant clinical concern, particularly in patients with underlying conditions.

Purpose of the Study:

• To prospectively investigate the incidence and risk factors of aminoglycoside nephrotoxicity in patients with extrahepatic obstructive jaundice.
• To identify specific predictors of nephrotoxicity in this patient population.

Main Methods:

• A prospective study involving 237 hospitalized adult patients classified into three groups.
• Group I: patients with extrahepatic obstructive jaundice receiving aminoglycosides (n=84).
• Group II: patients with extrahepatic obstructive jaundice not receiving aminoglycosides (n=81).
• Group III: non-cholestatic patients receiving aminoglycosides (n=72).

Main Results:

• Nephrotoxicity incidence was significantly higher in Group I (32%) compared to Group II (11%) and Group III (5.6%) (p < 0.00001).
• In Group I, higher serum bilirubin, aminoglycoside trough concentration, and half-life were associated with nephrotoxicity.
• Stepwise multivariate analysis identified serum total bilirubin level as the most significant predictor of nephrotoxicity.

Conclusions:

• Extrahepatic cholestasis, particularly with high serum bilirubin levels, is a distinct risk factor for aminoglycoside-induced nephrotoxicity.
• Close monitoring of renal function and serum bilirubin is crucial in patients with obstructive jaundice receiving aminoglycosides.